In summary, abnormalities in anti-apoptotic members of the BCL2 family, such as BCL2, MCL1, and BCL-w, lead to enhanced B cell survival and contribute to DLBCL development. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.